We previously reported that Pycnogenol , procyanidins extracted from the bark of French maritime ® pine (Pinus maritima Aiton; the official botanical name is now Pinus pinaster Aiton) is a potent free radical scavenger. It has been shown to inhibit macrophage oxidative burst. Macrophages carry out their microbicidal and tumoricidal activities via oxygen-dependent and oxygen-independent mechanisms. The present study investigated the effects of Pycnogenol on oxygen-independent killing mechanisms of macrophages, with 
Introduction
that p roduce a broad range of effects o n Macrophages play an important role in host defense by nonhematopoietic as well as hematopoietic cells phagocytizing foreign invaders, undergoing oxidative (Gupta, 1988; Oppenheim and Ruscetti, 1997) . The burst, presenting antigen, and secreting cytokines such activation of macrophages is regulated by a network of as tumor necrosis factor-alpha (TNF-") and interleukin-1 mediators. For example, TNF-" and IL-1$ enhance their beta (IL-1$). Macrophages are activated in inflammatory own release as well as that of each other (Durum and sites (Adams and Hamilton, 1984) . They can b e Oppenheim, 1989) . These two cytokines provide activated by bacterial lipopolysacchride, interferon-(, ILcostimulatory signals to enhance the activation of helper 12, IL-18, ultraviolet irradiation and ozone (Adams and T lymphocytes and thus promote both the humoral and Hamilton, 1984; Vairo et al., 1992; Munder et al., 1998;  cellular immune responses (Oppenheim and Ruscetti, Virgil et al., 1998) . An increase in cell size, protein 1997). content, and enzyme activity has been used as markers Pycnogenol (PYC) is a blend of water-soluble of macrophage activation (Adams and Hamilton, 1984;  oligomeric and monomeric procyanidins extracted from Enane et al., 1993) . The activated or "angry" the bark of French maritime pine (Pinus maritima Aiton; macrophages as they are sometimes called, can the official botanical name is now Pinus pinaster Aiton) efficiently destroy microbes, parasites, and tumor cells. (Masquelier, 1987) . It has been known to reduce Activated macrophages have been of interest in clinical inflammation, and alleviate a variety of conditions linked studies in local or systemic adoptive cancer to the deleterious action of free radicals (Passwater, immunotherapy as they can act selectively against 1992; Passwater and Kandaswami, 1994) . neoplastic cells (Bartholeyns, 1993) . TNF-", known for
In our laboratory, we have demonstrated that PYC can its cytotoxic effect on tumor cells, is secreted from protect vascular endothelial cells from injury induced by activated macrophages and monocytes (Currie and an organic oxidant, t-butyl hydroperoxide (Rong et al., Bashan, 1975) . IL-1$, also termed lymphocyte activating 1995). It can increase the levels of intracellular factor, has been known to protect against lethal changes glutathione and enhance the activities of antioxidant brought about by radiation, hyperoxia and infection enzymes (Wei et al., 1997) . PYC also inhibits (Gupta, 1988) . Through TNF-" and IL-1$ macrophages macrophage oxidative burst, lipoprotein oxidation, and control the proliferation, differentiation, and effector hydroxyl radical-induced DNA damage (Nelson et al. , functions of lymphocytes (Parslow and Bainton, 1997 means ± SE of three experiments. *Significant difference compared with control without PYC (P < 0.05).
impairment and memory deficit in senescence accelerated mice (Liu et al., 1998; Liu et al., 1999) . More recently, we showed that PYC protects neurons from amyloid-$ peptide-induced apoptosis (Peng et al. 2002) .
The clinical benefits of PYC have been summarized in a recent review article (Rohdewald, 2002) . In the present paper, we report the effects of PYC on activation of macrophages pertaining to cell size, phagocytosis, and secretion of TNF-" and IL-1$. Cell Line: The murine J774 macrophage cell line was obtained from the American Type Culture Collection (ATCC, Rockville, MD, U.S.A.). Cells were grown i n DMEM, supplemented with 10% BCS, 200 U/ml penicillin and 200 µg/ml streptomycin, for 3-5 days, at 37 C in a humidified 5% CO atmosphere. The viability of o 2 cells used in experiments was always greater than 95% as determined by trypan blue exclusion.
Materials and Methods

Chemicals
Phagocytosis
Assay:
The microfluorometric phagocytosis assay was performed in 96-well plates as previously described (Wan et al., 1993) . Suspension of fluorescein-conjugated E.coli particles (100 µl/well) was used to measure the ability of macrophages t o phagocytize these particles with or without PYC pretreatment. The results were expressed as the relative fluorescence unit.
Cell Size Measurement: J774 cells (7.4 x 10 cells/well) 5 were seeded in 6-well plates and incubated with PYC (8.75, 17.5, 35 , and 70 µg/ml) in DMEM at 37 C for 22 hr. Statistical Analyses: Experimental data were analyzed with one-way analysis of variance (ANOVA) followed by Tukey's multiple range test for significant difference, and the results were expressed as means ± SE. Statistical procedures were performed with Statgraphics software version 5.0 (STSC, Rockville, MD, U.S.A.).
Results
Each experiment was repeated at least three times with consistent results indicating that the assays used in this study were highly reproducible. Fig. 1 shows the effect of PYC on phagocytosis. PYC caused a concentrationdependent increase in the ability of J774 cells t o phagocytize the fluorescein-conjugated E. coli particles as reflected by an increase of relative fluorescence units. Significant increases were noted between 8.75 and 70 µg/ml of PYC. A concentration-dependent increase in cell size was observed when J774 cells were treated with PYC ( Fig. 2  and 3 ). Statistically significant increases of 15% and 50% were noted with 35 µg/ml and 70 µg/ml of PYC, respectively (Fig. 2) . J774 cells were treated with PYC for 22 hr and the supernatants were tested for TNF-" release. A concentration-dependent increase of TNF-" release was noted with significant increases of 47 and 67% noted at 35 and 70 µg/ml of PYC, respectively (Fig. 4) . Fig. 5 shows the IL-1$ release when J774 cells were treated with PYC. The IL-1$ was below the level of detection up to 17.5 µg/ml of PYC. However, it increased significantly at PYC dosages of 35 and 70 µg/ml. was collected and the TNF-" release was measured. Data represent means ± SE o f triplicate samples. *Significant difference compared with control without PYC (P < 0.05).
Discussion
Macrophages constitute a major part of the host defense system against infection and cancer. Macrophages carry out their microbicidal and tumoricidal activities by the oxygen-dependent killing via products of oxidative metabolism such as hydrogen peroxide, superoxide anion, and hydroxyl radical, and the oxygen-independent killing via cytokines and hydrolytic enzymes. W e previously reported that PYC inhibited generation o f reactive oxygen species such as peroxides i n macrophages (Bayeta and Lau, 2000) indicating its ability to abolish the oxygen-dependent killing mechanism. This inhibition is used to explain the antiinflammatory property of PYC reported in the literature (Blazso et al., 1994; Blazso et al., 1997) . Our curiosity to find out whether or not PYC affected the oxygenindependent killing mechanism prompted us t o investigate the effects of PYC on macrophage phagocytosis and cytokine secretion. TNF-" and IL-1$ were chosen for our investigation because these two cytokines play an important role in regulating normal immune functions. Data from this study indicate that PYC did not inhibit macrophage phagocytosis and secretion of TNF-" and IL-1$. On the contrary, incubation of macrophages with PYC resulted in a greater phagocytic activity and increased levels of TNF-" and IL-1$. Thus, even though our previous study showed PYC to cripple oxygen-dependent killing mechanism, it i s intriguing that the present study demonstrates PYC's ability to enhance phagocytosis and cytokine secretion-a part of the oxygen-independent killing mechanism of macrophages. An increase in cell size is one of the earliest characteristics observed in activated macrophages and is r elated to the degree and rate of cell spreading; activated cells spread more rapidly and to a greater extent than the resident cells (Adams and Hamilton, 1984; Enane et al., 1993) . We observed a significant increase in cell size with PYC indicating its ability to activate macrophages. Activated macrophages exhibit a greater phagocytic activity than the resident cells (Zelikoff et al., 1991) . In our study, PYC-treated macrophages indeed exhibited a greater phagocytic capability than the untreated cells. With as little as 8.75 µg/ml of PYC, the phagocytosis increased by 27% as compared with the untreated control cells (Fig. 1) . Activated macrophages are known to increase their secretion of hydrolytic enzymes and cytokines. We did not investigate hydrolytic enzymes in the present study. Previous studies have, however, demonstrated PYC's ability to enhance the activity of enzymes in endothelial cells and macrophages (Wei et al., 1997; Bayeta and Lau, 2000) . Bartholeyns, J., 1993. Monocytes and macrophages in The present study shows a significant increase of TNF-" and IL-1$ secretion when macrophages were incubated with PYC. These two cytokines are unique in that they enhance their own release as well as that of each other (Durum and Oppenheim, 1989) . In addition, they provide costimulatory signals to enhance the activation of helper T-lymphocytes and thus promote both the humoral (Blymphocytes) and the cell-mediated (T-lymphocytes) immune responses (Oppenheim and Ruscetti, 1997) . Several studies have demonstrated that PYC is a potent anti-inflammatory phytochemical (Blazso et al., 1994; Blazso et al., 1997; Bayeta and Lau, 2000) . PYC differs from currently used steroidal or non-steroidal antiinflammatory drugs in that it does not exhibit any adverse side-effects (Bayeta and Lau, 2000) . Unlike most antiinflammatory drugs that exert immunosuppressant activity against B-and T-lymphocytes, the present study shows PYC's ability to increase cytokines known t o promote immune functions. Cheshier et al. (1996) used retro virus and chronic ethanol intoxication to induce immunosuppression in mice. Feeding with PYC delayed the development of immune dysfunction in this animal model. PYC restored the imbalanced cytokine secretion by T-helper 1 and T-helper 2 cells, which are important in cellular and humoral immunity, respectively. In our study with senescence-accelerated mice, w e demonstrated that PYC can restore the immune and hemopoietic functions that are altered in the aging process. Feeding animals with PYC significantly improved the severely depressed B-and T-lymphocyte responses to mitogens (Liu et al., 1999) . These studies suggest that PYC can enhance B and T cell function and at the same time it can exert potent anti-inflammatory effects.
In conclusion, the data from this in vitro study indicate that PYC is capable of activating macrophages t o enhance phagocytosis and the secretion of TNF-" and IL-1$. These results suggest that PYC may play an important role in modulating the immunological function by means of macrophage activation. PYC has been shown to have potent anti-inflammatory property. Unlike anti-inflammatory drugs currently in use, PYC is a novel and unique therapeutic agent in that it does not exhibit immunosuppressant activity. Whether or not these beneficial effects occur in humans warrants further clinical studies.
